Clinical Trial Update: St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD) [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion status of a Phase 2/Phase 3 clinical trial evaluating St. John's Wort for Generalized Social Anxiety Disorder, sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Social Anxiety Disorder

Drugs mentioned

• St. John's Wort (Hypericum perforatum)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Anxiety Disorders, Mental Health | Phase 2, Phase 3 | Status: COMPLETED